Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLURE: Abatacept in Active Lupus Nephritis
NCT01714817Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Jan 2013
- Primary completion
- Nov 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 23
01
Overview
A Phase 3 trial of abatacept in lupus nephritis (LN), sponsored by Bristol Myers Squibb. Started Jan 2013; status: terminated.
02
Drugs
abatacept
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01714817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01714817.